Patellar tendinopathy · Review · 2021
Does adding shockwave to exercise help jumper's knee?
In this review of 37 trials, two trials tested adding shockwave to eccentric (slow-lowering) exercises for jumper's knee. After 12 weeks, pain and knee function were about the same as with sham shockwave plus the same exercises.
Similar to sham with the same exercises- trials in the review
- 37
- trials tested shockwave added to exercise
- 2
- weeks of follow-up
- 12
Good to know: The review's authors advised against shockwave for jumper's knee.
Challoumas D, Pedret C, Biddle M, et al. BMJ Open Sport & Exercise Medicine, 2021 · Read the paper ↗
How this study worked
Conceptual animation: a focused front converges, then spreads. Not to scale. Tap the field to send a pulse.
What happened
- trials
- 2
- Compared with
- Sham shockwave with the same eccentric exercises
Knee pain after 12 weeks
Difference in pain score (VAS) · shockwave + exercise vs sham + exercise
Show the numbers
| Difference (pain score points) | likely range | |
|---|---|---|
| Pain at 12 weeks | +0.1 | −0.8 to 1 |
What the trials used
- ESWT adjunct to eccentric exercise
- Two RCTs compared ESWT plus eccentric exercise with sham ESWT plus eccentric exercise at 12 weeks. The accessible narrative does not state device, energy, shock count or sessions; the Figure 3 caption names this two-study network comparison "eccentric exercise–decline squat versus focal extracorporeal shockwave therapy+eccentric exercise". Both groups received eccentric loading, so this is an adjunct comparison, not ESWT alone.
Who took part
Adults with jumper's knee in 37 trials; two trials (shockwave or sham, both with exercise) informed this comparison.
Side effects
The review did not report side effects for shockwave.
All the numbers and the full appraisal
Every reported result
The results, in numbers.
Adults (>18 years) with clinically diagnosed patellar tendinopathy, any duration/severity. The review included 37 RCTs covering 33 interventions; outcome-specific networks included 16 studies/17 interventions for short-term pain and 19 studies/21 interventions for short-term VISA-P.
Pain during sport preferred where available1 reported outcome
Pain (VAS)
Pain during sport preferred where available MD VAS points (95% CI)
ESWT+eccentric exercise versus sham ESWT+eccentric exercise; positive favors sham
2 studies
Reported estimate and confidence interval.
No statistically significant difference; p=0.84, I²=0%. The review states no clinically important difference.
Analysis details and source
Pooled pairwise estimate from two RCTs; moderate-strength evidence. Both arms received eccentric exercise.
Victorian Institute of Sports Assessment–Patella1 reported outcome
Patellar tendon function (VISA-P)
Victorian Institute of Sports Assessment–Patella MD VISA-P points (95% CI)
ESWT+eccentric exercise versus sham ESWT+eccentric exercise; negative favors sham
2 studies
Reported estimate and confidence interval.
No statistically significant difference; p=0.57, I²=0%. The review states no clinically important difference.
Analysis details and source
Pooled pairwise estimate from two RCTs; moderate-strength evidence.
How treatment was delivered
Two RCTs compared ESWT plus eccentric exercise with sham ESWT plus eccentric exercise at 12 weeks. The accessible narrative does not state device, energy, shock count or sessions; the Figure 3 caption names this two-study network comparison "eccentric exercise–decline squat versus focal extracorporeal shockwave therapy+eccentric exercise". Both groups received eccentric loading, so this is an adjunct comparison, not ESWT alone.
The accessible article narrative does not provide a pooled ESWT adverse-event result. Do not interpret this as evidence of no harms.
All network estimates had low or very low certainty because of high overall risk of bias, imprecision and intransitivity. Only two RCTs informed ESWT+eccentric versus sham+eccentric at 12 weeks; mid-/long-term NMA data were inadequate. ESWT protocol details are not given in the article text; study characteristics are in an online supplement and the network league tables in Figure 4, and neither the supplement nor the figure image was available.
Findings checked against the full source by a separate automated reviewer.
Limitations noted by the reviewers
- All network estimates had low or very low certainty because of high overall risk of bias, imprecision and intransitivity. Only two RCTs informed ESWT+eccentric versus sham+eccentric at 12 weeks; mid-/long-term NMA data were inadequate. ESWT protocol details are not given in the article text; study characteristics are in an online supplement and the network league tables in Figure 4, and neither the supplement nor the figure image was available.
Source-linked critical reading
Systematic review with network meta-analysis
Technical source record
Read full article, all five figure captions, methods, outcome time stratification, direct two-RCT ESWT comparison, short-term VAS/VISA-P network results, risk of bias, certainty ratings, discussion and recommendations. Supplement tables and figure pixels were unavailable.
Adding shockwave to eccentric exercise did not improve pain or function over sham plus the same exercise at 12 weeks. This review recommended against ESWT for patellar tendinopathy.
In adults with patellar tendinopathy, do available treatments improve pain and VISA-P function compared with other treatments, sham or no treatment?
Systematic review and pairwise/network meta-analysis of randomized studies; searches through May 2021. Thirty-seven RCTs covered 33 interventions. The review used frequentist NMA and GRADE/GRADE-NMA.
Adults over 18 with clinical patellar tendinopathy of any duration or severity were eligible. Sport type/level and prior treatment varied. Outcome networks were smaller than the full set of 37 trials.
Two RCTs tested ESWT added to eccentric exercise against sham ESWT with the same eccentric exercise. Device, energy, shock count and session details are not stated in accessible narrative.
The direct comparator was sham ESWT, with eccentric exercise in both groups. Across the network, sham/placebo was treated as no treatment.
Primary outcome was pain VAS (sports pain preferred where reported); VISA-P was secondary. At 12 weeks, pooled differences were pain MD +0.1 (95% CI −0.8 to 1.0) and VISA-P MD −1.8 (−8.0 to 4.4), with no statistical or clinical difference.
The direct pairwise evidence was moderate strength and found no short-term advantage of adding ESWT. NMA rankings favored other regimens for short-term outcomes but were low/very low certainty; mid/long-term NMA data were inadequate. The authors recommended against ESWT.
No pooled ESWT harm estimate was provided in accessible narrative; absence of a reported estimate is not evidence of no harm.
Most included studies had high/unclear risk of bias, networks were sparse, and rankings were limited by imprecision and intransitivity. The online supplement with study-level characteristics and the Figure 4 league-table image were unavailable.
The findings apply to patellar tendinopathy and the studied adjunct comparison. They do not establish that all ESWT protocols are identical, but the review does not support adding ESWT to eccentric exercise at 12 weeks.
Trials should report device, energy, session details, harms, validated outcomes and prespecified short-, mid- and long-term follow-up, with adequate sample sizes and low risk of bias.
Read the original article.
Management of patellar tendinopathy: a systematic review and network meta-analysis of randomised studies.
Challoumas D, Pedret C, Biddle M, Ng NYB, Kirwan P, Cooper B, Nicholas P, Wilson S, Clifford C, Millar NL. · BMJ open sport & exercise medicine · 2021
Open the publication record or available full-text files.
Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →